The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
- PMID: 32242121
- PMCID: PMC7117553
- DOI: 10.1038/s41584-020-0418-0
The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
Abstract
The global COVID-19 pandemic has the potential to severely affect those with rheumatic diseases or who are taking immunosuppressive therapies. Information is lacking as to how these groups will fare if they become infected. A global alliance has rapidly formed to try to address this information deficit.
Conflict of interest statement
P.C.R. declares no competing interests related to this work, but outside of this work he declares personal consulting and/or speaking fees from Abbvie, Eli Lilly, Janssen, Novartis, Pfizer and UCB and travel assistance from Roche. J.Y. declares no competing interests.
